- Meeting abstract
- Open Access
Echocardiography led to the evaluation of cardiopulmonary resuscitation
© Algaba-Montes et al; licensee Springer. 2014
- Published: 31 January 2014
- Pulmonary Embolism
- Cardiopulmonary Resuscitation
- Diagnostic Mode
- Cardiac Tamponade
The cardiopulmonary arrest (CA) is a critical situation, where ultrasound is the only diagnostic mode with the possibility of direct action during cardiopulmonary resuscitation (CR) in real time, without interfering with the resuscitation maneuvers. Through a structured process with a focused ultrasound (US) examination procedure conforming to the universal algorithm in cardiopulmonary resucitation, and using the Protocol FEER, it is possible to recognize the relevant pathology and more user-friendly wich cause CA or pulseless electrical activity.
To know the utility of ultrasonography in the diagnosis and management of the CA.
Literature review of articles published up to December 2011 related to the use of ultrasound as an aid to making decisions and diagnosis in the context of a CA. Key words: Focused echocardiography evaluation resuscitation. Critical care ultrasound.
The FEER Protocol is a procedure that consists of 10 steps, and that must be run simultaneously during the cycles of CR to reduce interruptions of cardiac massage, with a four chambers subcostal view, and medioclavicular of both hemithorax. Evaluate if there is a cardiac tamponade (CT), severe hypovolemia (SH), pulmonary embolism (PE) or tension pneumothorax (TP).
The absence of cardiac mobility objectified with ultrasound, regardless of whether there is or not electrical activity, is associated with refractoriness to the manoeuvres of cardiopulmonary resuscitation and fatal outcome.
US during CR reduces the time required to determine the cause of cardiac arrest (CT, SH, PE, TP), and thus to decrease the time until an effective treatment, in addition to detecting whether or not mechanical activity in the heart and distinguish true pulseless electrical activity.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.